Blocking accounts for variation associated with a known participant or study characteristic before treatment effects are assessed. Because interventions are compared within groups that are more alike, differences related to age, disease severity, or treatment center are less likely to obscure the intervention signal. This can produce more reliable estimates of treatment effects than comparisons affected by substantial baseline variation.
Blocking makes participants within a group more comparable, but it does not determine which intervention each participant receives. Random assignment within the block distributes treatments without selecting participants according to expected outcomes. This preserves a fair comparison while allowing the design to control variation from the characteristic used to form the block.
It is especially useful when investigators know that an important characteristic differs across participants or sites and could influence outcomes. Age, disease severity, and treatment center are examples identified in the clinical context. Organizing participants around such differences helps prevent meaningful treatment effects from being masked by pre-existing variation.
Blocks can be based on characteristics expected to create important differences among study participants or clinical settings. The overview identifies age, disease severity, and treatment center as relevant examples. These factors may reflect baseline differences or site-related variation, so grouping by them supports comparisons among participants with more similar starting conditions.
First, investigators identify a known factor that may contribute to outcome variation, such as age, disease severity, or treatment center. They then group participants into corresponding blocks and randomly assign the interventions separately within each block. The resulting treatment comparisons use these organized groups to reduce the influence of the selected source of variation.
Treatment center can serve as a blocking factor when a trial includes multiple sites. Randomizing interventions within each center helps prevent site-related differences from dominating the comparison, while preserving the trial's focus on intervention effects. This is relevant when outcomes might otherwise reflect differences between centers rather than differences attributable to the treatments.